» Articles » PMID: 4812773

Proceedings: A Controlled Study of Combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil Therapy for Advanced Gastric and Pancreatic Cancer

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1974 Feb 1
PMID 4812773
Citations 25
Authors
Affiliations
Soon will be listed here.
Citing Articles

Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer.

Cao B, Cao Q, Ma X, Ou K, Yang W, Zhang L BMC Cancer. 2025; 25(1):449.

PMID: 40075310 PMC: 11905668. DOI: 10.1186/s12885-025-13799-5.


Chemotherapy and radiotherapy for advanced pancreatic cancer.

Haggstrom L, Chan W, Nagrial A, Chantrill L, Sim H, Yip D Cochrane Database Syst Rev. 2024; 12:CD011044.

PMID: 39635901 PMC: 11619003. DOI: 10.1002/14651858.CD011044.pub3.


The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress.

Finan J, Di Niro R, Park S, Jeong K, Hedberg M, Smith A Cancer Biol Ther. 2024; 25(1):2421584.

PMID: 39513592 PMC: 11552260. DOI: 10.1080/15384047.2024.2421584.


Chemotherapy and radiotherapy for advanced pancreatic cancer.

Chin V, Nagrial A, Sjoquist K, OConnor C, Chantrill L, Biankin A Cochrane Database Syst Rev. 2018; 3():CD011044.

PMID: 29557103 PMC: 6494171. DOI: 10.1002/14651858.CD011044.pub2.


Chemotherapy for advanced gastric cancer.

Wagner A, Syn N, Moehler M, Grothe W, Yong W, Tai B Cochrane Database Syst Rev. 2017; 8:CD004064.

PMID: 28850174 PMC: 6483552. DOI: 10.1002/14651858.CD004064.pub4.